http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115116570-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80cb533deeefa859b434ddcfd9967bb1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-40 |
filingDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b42613f35ef22284ef87f95a42ad5462 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ebf465fd21fd54a283ab164bfdb4b04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_672c4ce5ced447d2416cf3e734756c84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_240f10011db5044cdc1fb7987363e921 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d5627fb7d7783c953f76bdfacf2724d |
publicationDate | 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-115116570-A |
titleOfInvention | A screening method for preeclampsia in early pregnancy |
abstract | The invention discloses a screening method for preeclampsia in early pregnancy, which relates to the field of medical detection, including (1) taking preeclampsia and chronic hypertension with preeclampsia as a research group, and taking normal pregnant women as a control group; (2) ) detected the serum biochemical indicators of pregnancy-related protein A and placental growth factor in all pregnant women, and measured the mean arterial pressure and uterine artery pulsatility index of both arms, and compared the distribution of their median multiples MOM; (3) According to the detection data of all pregnant women, use The median equation of the localized preeclampsia screening markers in the first trimester of gestation was constructed to modify the risk calculation model, and the risk of preeclampsia was predicted according to the 15% false positive rate corresponding to a reasonable cut-off value. The invention has the beneficial effects that it can be applied to pregnant women in China to perform preeclampsia screening in early pregnancy, improve the detection rate of preeclampsia screening, and reduce the incidence and mortality of critically ill pregnant women through early prevention. |
priorityDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.